Ludovic Ferrer
Ludovic Ferrer
ICO René Gauducheau
Verified email at
TitleCited byYear
GATE: a simulation toolkit for PET and SPECT
S Jan, G Santin, D Strul, S Staelens, K Assie, D Autret, S Avner, R Barbier, ...
Physics in Medicine & Biology 49 (19), 4543, 2004
Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by (18F Fluorodeoxyglucose Positron Emission Tomography
CDA Rousseau, CFL Sagan, BCL Bridji, MBE Ricaud, ICM Doutriaux, ...
Journal of clinical oncology 24 (34), 5366-5372, 2006
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization …
F Kraeber-Bodéré, C Rousseau, C Bodet-Milin, L Ferrer, ...
Journal of Nuclear Medicine 47 (2), 247-255, 2006
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial
F Kraeber-Bodéré, S Bardet, CA Hoefnagel, MR Vieira, JP Vuillez, ...
Clinical cancer research 5 (10), 3190s-3198s, 1999
ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine
F Haddad, L Ferrer, A Guertin, T Carlier, N Michel, J Barbet, JF Chatal
European Journal of Nuclear Medicine and Molecular Imaging 35 (7), 1377-1387, 2008
High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer
E Mirallie, JP Vuillez, S Bardet, E Frampas, B Dupas, L Ferrer, ...
The Journal of Clinical Endocrinology & Metabolism 90 (2), 779-788, 2005
Nuclear medical imaging using β+ γ coincidences from 44Sc radio-nuclide with liquid xenon as detection medium
C Grignon, J Barbet, M Bardiès, T Carlier, JF Chatal, O Couturier, ...
Nuclear Instruments and Methods in Physics Research Section A: Accelerators …, 2007
Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT
T Carlier, T Eugène, C Bodet-Milin, E Garin, C Ansquer, C Rousseau, ...
EJNMMI research 3 (1), 11, 2013
Monte Carlo modeling of gamma cameras for I-131 imaging in targeted radiotherapy
D Autret, A Bitar, L Ferrer, A Lisbona, M Bardiès
Cancer biotherapy & radiopharmaceuticals 20 (1), 77-84, 2005
Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen× anti-hapten bispecific antibody-mediated pretargeting of iodine-131-labeled hapten in …
F Kraeber-Bodéré, A Faivre-Chauvet, L Ferrer, JP Vuillez, PY Brard, ...
Clinical cancer research 9 (10), 3973s-3981s, 2003
Radioimmunoconjugates for the treatment of cancer
F Kraeber-Bodéré, C Bodet-Milin, C Rousseau, T Eugène, A Pallardy, ...
Seminars in oncology 41 (5), 613-622, 2014
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients
C Rousseau, A Devillers, M Campone, L Campion, L Ferrer, C Sagan, ...
European journal of nuclear medicine and molecular imaging 38 (6), 1029-1036, 2011
Effect of patient morphology on dosimetric calculations for internal irradiation as assessed by comparisons of Monte Carlo versus conventional methodologies
A Divoli, S Chiavassa, L Ferrer, J Barbet, GD Flux, M Bardies
Journal of Nuclear Medicine 50 (2), 316-323, 2009
Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients
C Rousseau, L Ferrer, S Supiot, M Bardiès, F Davodeau, ...
Tumor Biology 33 (3), 679-688, 2012
Prospective comparison of 3 γ-probes for sentinel lymph node detection in 200 breast cancer patients
JM Classe, M Fiche, C Rousseau, C Sagan, F Dravet, R Pioud, A Lisbona, ...
Journal of Nuclear Medicine 46 (3), 395-399, 2005
Comparison of electron dose-point kernels in water generated by the Monte Carlo codes, PENELOPE, GEANT4, MCNPX, and ETRAN
H Uusijärvi, N Chouin, P Bernhardt, L Ferrer, M Bardies, ...
Cancer biotherapy and radiopharmaceuticals 24 (4), 461-467, 2009
Voxeldose: a computer program for 3-D dose calculation in therapeutic nuclear medicine
I Gardin, LG Bouchet, K Assié, J Caron, A Lisbona, L Ferrer, WE Bolch, ...
Cancer Biotherapy and Radiopharmaceuticals 18 (1), 109-115, 2003
Implementing dosimetry in GATE: Dose-point kernel validation with GEANT4 4.8. 1
L Ferrer, N Chouin, A Bitar, A Lisbona, M Bardiès
Cancer biotherapy & radiopharmaceuticals 22 (1), 125-129, 2007
Radioimmunotherapy of B-cell non-Hodgkin’s lymphoma
C Bodet-Milin, L Ferrer, A Pallardy, T Eugène, A Rauscher, ...
Frontiers in oncology 3, 177, 2013
Cluster computing software for GATE simulations
J De Beenhouwer, S Staelens, D Kruecker, L Ferrer, Y D'Asseler, ...
Medical physics 34 (6Part1), 1926-1933, 2007
The system can't perform the operation now. Try again later.
Articles 1–20